By Jason Peterson, RPh; Beckie Fenrick, PharmD; and Long Tran, PharmD
As families prepare for a new school year, immunization records are back on the radar alongside physicals, school forms and other preventive care. This year, federal childhood vaccine guidance is also in flux.
Officials revised the childhood immunization schedule earlier this year, but those changes were later blocked in court, leaving the July 2025 schedule in effect while additional federal action points to further changes ahead.
For employers, TPAs, brokers and consultants, understanding what applies now and what may change can help inform health plan coverage and member communications heading into the school year.
What Childhood Vaccine Schedule Is in Effect in 2026?
In January 2026, federal health officials revised the childhood immunization schedule, shifting recommendations for several vaccines from broad routine recommendations to certain high-risk groups or shared clinical decision-making.
Those revisions were challenged in court by the American Academy of Pediatrics, the American College of Physicians and other organizations, and on March 16, 2026, the U.S. District Court for the District of Massachusetts issued a preliminary injunction temporarily blocking implementation of the revised schedule. The federal government filed a notice of appeal on April 29.
For now, the CDC identifies the July 2, 2025 child and adolescent immunization schedule as the operative federal schedule.
At the same time, additional federal action is signaling where future recommendations may be headed. Executive Order 14420, signed August 10, directs federal agencies to take additional steps related to childhood vaccine recommendations, including transitioning some vaccines to shared clinical decision-making rather than broad routine recommendations.
Which Childhood Vaccine Recommendations Could Change in 2026?
Shared clinical decision-making, or SCDM, involves a case-by-case discussion between a clinician and family rather than a broad recommendation for everyone within an age group.
Many core childhood vaccines, including MMR, IPV, DTaP/Tdap, Hib, PCV and varicella, remain listed as routine across the current and proposed approaches. Other recommendations show some potential changes:
| Vaccine / Recommendation | Current Schedule Issued July 2025 | January 2026 Schedule | August 2026 Executive Order |
| Measles, Mumps, Rubella (MMR) | Routine | Routine | Routine |
| Inactivated Polio Virus (IPV) | Routine | Routine | Routine |
| Pertussis/Tetanus/Diphtheria (DTaP/Tdap) | Routine | Routine | Routine |
| Hib (Haemophilus influenzae type B) | Routine | Routine | Routine |
| Pneumococcal (PCV) | Routine | Routine | Routine |
| HPV (Human Papillomavirus) | Routine, 2–3 doses | Routine, proposed 1-dose approach | Routine |
| Varicella (Chickenpox) | Routine | Routine | Routine |
| Influenza | Routine annually | SCDM | SCDM |
| Rotavirus | Routine | SCDM | SCDM |
| Hepatitis A | Routine and certain high-risk groups | Certain high-risk groups; SCDM for others | SCDM |
| Hepatitis B | Routine | High-risk groups; SCDM for others | High-risk groups; SCDM for others |
| Dengue | Certain high-risk groups | Certain high-risk groups | Certain high-risk groups |
| Meningococcal ACWY | Routine adolescent and certain high-risk groups | High-risk groups; SCDM for others | High-risk groups; SCDM for others |
| Meningococcal B | Certain high-risk groups; SCDM for others | Certain high-risk groups; SCDM for others | High-risk groups; SCDM for others |
| RSV monoclonal antibody | Certain high-risk groups | Certain high-risk groups | Certain high-risk groups |
| COVID-19 | SCDM | SCDM | SCDM |
For plan sponsors, these changes matter beyond compliance alone. Preventive immunizations can help reduce avoidable healthcare costs and support workforce health, making continued access and clear member communication important considerations as federal guidance evolves.
Do Federal Vaccine Changes Affect School Vaccine Requirements?
Changes to federal vaccine recommendations do not directly change school-entry requirements, which are established under state and local law.
All states require certain vaccinations for children entering school or childcare, but the specific vaccines, documentation requirements and available exemptions vary. For example, MMR vaccination is required by all 50 states, while PCV requirements vary by state.
For families, that means federal guidance may be changing while school requirements remain different depending on where they live. Employers and benefit partners should keep that distinction clear in any back-to-school communications and direct employees to their school, state health department or child’s doctor for specific requirements.
How Childhood Vaccine Changes Could Affect Employer Health Plan Coverage
Federal vaccine recommendations can also affect preventive coverage under employer-sponsored health plans.
Under the Affordable Care Act, non-grandfathered group health plans generally must cover ACIP-recommended immunizations without cost-sharing when they are provided in-network and administered in accordance with the applicable recommendation.
That coverage still applies when a vaccine is recommended through shared clinical decision-making. Federal guidance recognizes that some ACIP recommendations are intended for specific individuals rather than an entire population, and preventive coverage may apply when a clinician recommends a vaccine consistent with that guidance.
As federal vaccine guidance continues to evolve, employers, TPAs and advisors should monitor:
- CDC and HHS guidance that could affect vaccine recommendations and preventive-service coverage
- State and local requirements that determine school and childcare vaccination rules
- Medical and pharmacy benefit administration, where applicable, to identify any coverage or coordination changes
- Member communications that may need to be updated as recommendations, coverage requirements or school-entry policies change
For plan sponsors, staying current on these developments can help ensure benefit administration and member communications keep pace as federal recommendations evolve.
Staying Ready as Vaccine Guidance Changes
The biggest challenge for plan sponsors may be less about predicting where federal vaccine policy ultimately lands and more about being prepared to respond when recommendations change.
Staying current on the guidance in effect can help employers make informed coverage decisions, update member communications when needed, and continue supporting access to preventive care. As vaccine policy evolves, immunization remains relevant not only from a coverage perspective, but also as part of broader efforts to support workforce health and manage avoidable healthcare costs.
Need help navigating how changing clinical guidance could affect your pharmacy benefit? Navion helps plan sponsors and their partners translate new developments into informed benefit decisions.
